Systemic side effects of eye drops: a pharmacokinetic perspective

A Farkouh, P Frigo, M Czejka - Clinical ophthalmology, 2016 - Taylor & Francis
When administering eye drops, even when completely correctly applied, several routes of
absorption are possible and excess amounts can sometimes cause an unwanted systemic …

Cardiac safety of ophthalmic timolol

J Mäenpää, O Pelkonen - Expert Opinion on Drug Safety, 2016 - Taylor & Francis
Introduction: It is generally believed that topical administration of eye drops safeguards
against harmful systemic effects. However, about 80% of the drug in the ophthalmic products …

Meta‐analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

VV Upreti, JL Wahlstrom - The Journal of Clinical …, 2016 - Wiley Online Library
The accurate prediction of pharmacokinetics (PK) is fundamental to underwriting safety and
efficacy in pediatric clinical trials; age‐dependent PK may be observed with pediatrics …

Specific features of pharmacokinetics in children

P Matalová, K Urbánek… - Drug metabolism reviews, 2016 - Taylor & Francis
Human growth and development consist of a continuum of biological events. The impact of
these developmental changes in drug disposition is largely related to changes in the body …

Development of human membrane transporters: drug disposition and pharmacogenetics

MG Mooij, AT Nies, CAJ Knibbe, E Schaeffeler… - Clinical …, 2016 - Springer
Membrane transporters play an essential role in the transport of endogenous and
exogenous compounds, and consequently they mediate the uptake, distribution, and …

Age-specific regulation of drug-processing genes in mouse liver by ligands of xenobiotic-sensing transcription factors

CY Li, HJ Renaud, CD Klaassen, JY Cui - Drug Metabolism and Disposition, 2016 - ASPET
The xenobiotic-sensing transcription factors (xeno-sensors) AhR, CAR, and PXR upregulate
the expression of many drug-processing genes (DPGs) in liver. Previous studies have …

Characterization of atomoxetine biotransformation and implications for development of PBPK models for dose individualization in children

JC Dinh, RE Pearce, L Van Haandel, A Gaedigk… - Drug Metabolism and …, 2016 - ASPET
Atomoxetine (ATX) is a second-line nonstimulant medication used to control symptoms of
attention deficit hyperactivity disorder (ADHD). Inconsistent therapeutic efficacy has been …

SLC22A1/OCT1 genotype affects O-desmethyltramadol exposure in newborn infants

M Matic, SN de Wildt, L Elens, JN de Hoon… - Therapeutic Drug …, 2016 - journals.lww.com
Background: This study determined whether the SLC22A1 [encoding the organic cation
transporter 1 (OCT1)] genotype could explain, in addition to the postmenstrual age (referring …

Pharmacogenomic information in FDA‐approved drug labels: application to pediatric patients

DJ Green, P Mummaneni, IW Kim… - Clinical …, 2016 - Wiley Online Library
Pharmacogenomic (PGx) information is increasingly being incorporated into US Food and
Drug Administration‐approved drug labels. We reviewed the data source (adults vs …

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?

ANA Daud, JEH Bergman… - International Journal of …, 2016 - mdpi.com
Serotonin reuptake inhibitors (SRIs) are often prescribed during pregnancy. Previous
studies that found an increased risk of congenital anomalies, particularly congenital heart …